Psychosomatic Medicine 36:47-56 (1974)
© 1974 American Psychosomatic Society

Peripheral Versus Central Mechanisms Accounting for Antianxiety Effects of Propranolol

¹ University of California, Irvine, California, and the University of Cincinnati, Cincinnati, Ohio

Address reprint requests to: L.A. Gottschalk, M.D., Dept. of Psychiatry and Human Behavior, College of Medicine, University of California, Irvine, California 92664

A -adrenergic blocking agent, propranolol (60 mg orally in three divided doses over a 12-hr period), significantly reduced basal anxiety scores in 12 healthy, nonanxious subjects as compared to a placebo in another 12 similar subjects. In response to a 10-min stress interview, anxiety scores increased to equal levels, whether subjects were on propranolol or a placebo. On placebo, anxiety scores correlated positively (+0.70) with average plasma FFA. On propranolol, anxiety scores correlated negatively (-0.55) with plasma FFA and the average pulse rate was significantly lowered. The experimental findings suggest that basal or resting anxiety may be maintained by peripheral afferent autonomic biofeedback, and the latter can be reduced by -adrenergic blocking agents; whereas, the magnitude of acutely aroused anxiety is mediated more through the central nervous system.

This article has been cited by other articles:

				P. Terry and P. Salmon Biphasic effects of propranolol on a temporal generalization gradient in the rat J Psychopharmacol, January 1, 1990; 4(2): 63 - 68. [Abstract] [PDF]

				L. A. Gottschalk and F. Lolas The Gottschalk-Gleser Content Analysis Method of Measuring the Magnitude of Psychological Dimensions: Its Application in Transcultural Research Transcultural Psychiatry, January 1, 1989; 26(2): 83 - 111. [PDF]

				M. R. Liebowitz, J. M. Gorman, A. J. Fyer, and D. F. Klein Social Phobia: Review of a Neglected Anxiety Disorder Arch Gen Psychiatry, July 1, 1985; 42(7): 729 - 736. [Abstract] [PDF]